Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fatimah Alotaibi"'
Autor:
Hisham S. Abou-Auda, Fatimah Alotaibi, Sary Alsanea, Abdulrahman Alwhaibi, Mohammed M. Almutairi, Ziyad Alrabiah, Abdullah Alsultan, Majed Al Jeraisy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102060- (2024)
Understanding the pharmacokinetics of gentamicin is essential in special populations, such as pediatric patients with acute lymphoblastic leukemia (ALL), in light of previous studies indicating that ALL patients have a lower volume of distribution th
Externí odkaz:
https://doaj.org/article/990726c480da470ea9657ed7812e2c82
Autor:
Abeer Alanazi, Reem Almuhaya, Mohammad Almohaimeed, Nada Alahmari, Noor Abdulrahim, Marouj Basyouni, Farah Althikrallah, Jumanah Al Badwyi, Abdulrahman Khallaf, Khalid Albalawi, Amal Almalki, Khalid Alsaedi, Fatima Bakarman, Fatimah Alotaibi, Mohammed Kanan
Publikováno v:
Pharmacoepidemiology, Vol 2, Iss 4, Pp 289-306 (2023)
Overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria and pose a significant threat due to adverse drug reactions, increased healthcare costs, and poor patient outcomes. Antibiotic stewardship programs, includin
Externí odkaz:
https://doaj.org/article/1cd67c716e0442b0817c902d98a702ab
Autor:
Dina A. Bakhotmah, Fatimah Alotaibi
Publikováno v:
European Journal of Chemistry. 11:198-205
New fluorine-substituted polyfunctional pyrimido-[1,2-b]-[1,2,4]triazines and [1,3,5]-triazino[1,2-b]-[1,2,4]triazines were synthesized via the reaction between 3-amino-6-(2-aminophenyl)-1,2,4-triazin-5(2H)-one with polyfunctional oxygen/sulfur/nitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f0ba7cbde448068c80f3d198ab2070a
https://doi.org/10.5155/eurjchem.11.3.198-205.1988
https://doi.org/10.5155/eurjchem.11.3.198-205.1988
Autor:
Ronald B. Postuma, Amélie Pelletier, Fatimah Alotaibi, Jean-François Gagnon, Jacques Montplaisir
Publikováno v:
Movement Disorders. 34:1914-1919
Objective To estimate prodromal marker progression in idiopathic rapid eye movement sleep behavior disorder patients with prodromal Parkinson's disease (PD) to calculate sample size for neuroprotective trials. Methods Patients with polysomnogram-prov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056370aea8dad36cd4119c1ced69aa4a
https://doi.org/10.1002/mds.27869
https://doi.org/10.1002/mds.27869